New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsCompareCJC-1295 vs Somatropin (HGH)

CJC-1295 vs Somatropin (HGH)

Side-by-side comparison of key properties, dosing, and research.

Growth Hormone Peptides
CJC-1295
Growth Hormone PeptidesAnti-Aging & Longevity
Somatropin (HGH)
Summary
CJC-1295 is a synthetic GHRH analog that stimulates the pituitary gland to produce and release growth hormone. The DAC (Drug Affinity Complex) version has a markedly extended half-life. The No DAC version (Modified GRF 1-29) preserves natural pulsatile GH release and is preferred in most protocols.
Somatropin is recombinant human growth hormone (rhGH), identical in structure to the 191-amino acid pituitary-derived growth hormone. It is FDA-approved for growth hormone deficiency, short stature, and wasting conditions. Off-label, it is widely explored for body composition, anti-aging, and performance enhancement, though significant risks accompany unsupervised use.
Half-Life
~30 minutes (No DAC) / 6–8 days (with DAC)
2-3 hours (subcutaneous); 20-30 minutes (intravenous)
Admin Route
SubQ
Subcutaneous, Intramuscular (less common)
Research
Typical Dose
100 mcg
0.15-0.3 mg/day (adults); titrated to IGF-1 levels
Frequency
Once daily, before bed
Once daily
Key Benefits
  • Sustained increase in growth hormone levels
  • Enhanced muscle growth and strength
  • Improved fat metabolism and body composition
  • Better recovery and tissue repair
  • Increased bone density
  • Enhanced immune function
  • Improved skin quality and collagen production
  • Synergistic GH release when combined with GHRPs like Ipamorelin
  • Increases lean muscle mass and reduces body fat (particularly visceral)
  • Restores growth hormone deficiency (FDA-approved)
  • Improves bone mineral density
  • Enhances exercise capacity and recovery
  • Supports skin thickness and collagen synthesis
  • Improves lipid profile in GHD patients
  • Explored for anti-aging and cellular regeneration
Side Effects
  • Water retention / puffiness
  • Carpal tunnel syndrome (with prolonged use)
  • Injection site irritation
  • Hunger increase (minor)
  • +1 more
  • Fluid retention and edema (common, dose-dependent)
  • Carpal tunnel syndrome
  • Joint and muscle pain
  • Insulin resistance and elevated blood glucose
  • +3 more
Stacks With